Although the majority of PSP and CBD cases are sporadic, certain MAPT mutations can result in clinical phenotypes and pathological features that are indistinguishable from PSP or CBD and may be considered the monogenetic causes of PSP and CBD [173]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.